☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Thyroid Cancer
Exelixis' Cabometyx (cabozantinib) Receives the US FDA's Approval for the Treatment of Locally Advanced or Metastatic Differentiat...
September 20, 2021
Interpace Diagnostics Signs an AI-Driven Agreement with Predictive Oncology for Diagnosing Thyroid Cancer
July 19, 2019
AstraZeneca Fails to Prove the Drug Selumetinib for Thyroid cancer
July 26, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.
